EAPC 2020: Dental Treatment Is a Risk Factor for Denosumab-Induced Osteonecrosis of the Jaw in Patients With Bone Metastases
Incidence of the disorder was found to be clinically relevant.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.